Stay updated on Toripalimab+Surufatinib in Advanced Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Toripalimab+Surufatinib in Advanced Thyroid Cancer Clinical Trial page.

Latest updates to the Toripalimab+Surufatinib in Advanced Thyroid Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference3%

- Check27 days agoChange DetectedUpgrade to v3.1.0 with new contact details added (phone and emails); previous v3.0.2 deleted.SummaryDifference0.1%

- Check42 days agoChange DetectedUpdated revision from v3.0.1 to v3.0.2 and removed the 'Back to Top' link. No significant changes to core content.SummaryDifference0.2%

- Check49 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.2%

- Check56 days agoChange DetectedThe web page has added specific drug information for Toripalimab and surufatinib, along with a new facility name and location details, while removing previous location terms and some related topics.SummaryDifference2%

- Check70 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%

Stay in the know with updates to Toripalimab+Surufatinib in Advanced Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Toripalimab+Surufatinib in Advanced Thyroid Cancer Clinical Trial page.